Targeted therapies: Bevacizumab and heart failure

Nature Reviews Clinical Oncology

Volumn 8, Issue 3, 2011, Pages 124-

  Kirk, Rebecca ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; DISEASE ASSOCIATION; DRUG TARGETING; HEART FAILURE; HUMAN; NOTE; PRIORITY JOURNAL; SOLID TUMOR;

EID: 79952385863     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2011.11     Document Type: Note

References (1)

1. Choueiri, T. K. et al. Congestive heart failure risk in patients with breast cancer treated with bevacizumab. J. Clin. Oncol. doi:10.1200/JCO.2010.31. 9129